Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Capital Expenditures (2023)

Rallybio's Capital Expenditures history spans 1 years, with the latest figure at $12000.0 for Q3 2023.

  • For Q3 2023, Capital Expenditures changed N/A year-over-year to $12000.0; the TTM value through Dec 2024 reached $12000.0, changed 0.0%, while the annual FY2023 figure was $12000.0, 77.78% down from the prior year.
  • Capital Expenditures for Q3 2023 was $12000.0 at Rallybio.
  • Across five years, Capital Expenditures topped out at $12000.0 in Q3 2023 and bottomed at $12000.0 in Q3 2023.